Pimozide
Intellectual Disability
Fundación Pública Andaluza para la gestión de la Investigación en SevillaSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Intellectual Disability cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Guanfacine Maimonides Medical Center | Phase 4 | BB |
Metformin Centre for Addiction and Mental Health | Phase 4 | BB |
nt 201 Merz Pharmaceuticals GmbH | Phase 3 | BB |
Letrozole Centre for Addiction and Mental Health | Phase 4 | BB |
Risperdal Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Phase 2 | CCC |
View all 9 →
Same molecule, other indications
Pimozide is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →